SEC Tracker
Get the app

Lisata Therapeutics LSTA

Lisata Therapeutics: reports quarterly results

Form
8-K
Filed
Period
Importance
Major
Document
8-K
  • Reports quarterly results (2.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Lisata Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Nanoviricides NNVC public float $24M, Dec 31, 2025
  2. Tenax Therapeutics TENX public float $24M, Jun 30, 2025
  3. Aytu Biopharma AYTU public float $24M, Dec 31, 2025
  4. Dyadic International DYAI public float $24M, Jun 30, 2025
  5. Kala Bio KALA public float $25M, Jun 30, 2025